Charalampia Kyriakou, M.D.
Dr Charalampia Kyriakou obtained her medical degree from the Aristotelion University of Thessaloniki, Greece and subsequently trained in haemato-oncology in the transplant unit at George Papanikolaou Hospital. She moved to University College London Hospital in London in 1997 where she completed a transplant followed by myeloma clinical fellowship. From 2002 to 2005 she was awarded the myeloma research fellowship and received her doctorate in mesenchymal stem cell research from Royal Free and University College London Medical School. Her basic research interest is focused on mesenchymal stem cell homing, gene transduction with anti-tumour genes and effect in in vivo lymphoma and myeloma mouse animal model together with in vitro interactions with lymphoma and myeloma cells. She is a member of the American Society of Hematology and Clinical Oncology. She is active member of the EBMT Lymphoma working party and her clinical interest is on transplantation for lymphoma and myeloma. She is currently the Lymphoma and Myeloma Lead at the North West London Hospital NHS Trust.
Clinical Trials: https://clinicaltrials.gov/ct2/results?term=Kyriakou+Waldenstrom%27s